FindTrial
Sign In

easypod™

DEVICE15 trials

Sponsors

Merck KGaA, Darmstadt, Germany

Conditions

Growth Disorders

Unknown Phase

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment
CompletedNCT01267526
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-05-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France
CompletedNCT01291394
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-01-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Austria
CompletedNCT01296425
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-07-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Sweden
CompletedNCT01307059
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-06-30End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Australia
CompletedNCT01309555
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-04-30End: 2016-10-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Greece
CompletedNCT01363674
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2013-04-30End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain
CompletedNCT01376921
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2012-09-30End: 2015-03-31Updated: 2017-12-26
Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic
CompletedNCT01400997
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-09-30End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Slovakia
CompletedNCT01400984
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2011-12-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Hungary
CompletedNCT01402999
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2012-05-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Mexico
CompletedNCT01555528
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2012-04-30End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
CompletedNCT01582334
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2013-03-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ (ECOS Taiwan, Indonesia, Singapore)
CompletedNCT02015273
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2014-02-28End: 2015-12-31Updated: 2020-07-07
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East
CompletedNCT02015286
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2014-03-31End: 2015-12-31Updated: 2017-12-26
To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Columbia
CompletedNCT02208076
Merck KGaA, Darmstadt, GermanyGrowth Disorders
Start: 2014-07-31End: 2015-12-31Updated: 2017-12-26

Related Papers

Adherence and long-term outcomes of therapy in paediatric patients in Greece using the easypod™ electromechanical device for growth hormone treatment: The phase IV multicentre easypod™ connect observational study (ECOS).
2020-07-186 citations
Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
2020-04-0112 citations